← back to search

Jie He

First Affiliated Hospital of Jinan University · CN
Area of research
Pulmonary and Respiratory Medicine · Surgery
Research interest
Research interests include Esophageal Cancer Research and Treatment, Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment, and Cancer Immunotherapy and Biomarkers.
h-index
91
citations
56,385
works
943
NIH funding
primary concept
Medicine
email

Recent publications

Inhibiting ADAR1-Mediated Excessive Epigenetic A-to-I RNA Editing Improves the Immune Microenvironment and Increases Sensitivity to Immunotherapy in Lung Adenocarcinoma.
2026cited by 0position: contributordoi
Clinical Benefit of PD-1/PD-L1 Inhibitors as Standard First-Line Treatment in Low PD-L1-Expressing Advanced Solid Tumors: A Systematic Review and Meta-Analysis.
2026cited by 0position: contributordoi
Treatment patterns and clinical outcomes of neoadjuvant chemoimmunotherapy for patients with resected oesophageal squamous cell carcinoma: a Chinese multicentre retrospective study.
2026cited by 0position: contributordoi
Integrated multi-omics analyses identified the H3K18la-based spatiotemporal characteristics and risk-stratified treatment strategy in lung adenocarcinoma
Cancer Letters 2026cited by 0position: contributordoi
Tertiary lymphoid structures as a biomarker in immunotherapy and beyond: Advancing towards clinical application
Cancer Letters 2025cited by 28position: contributordoi
Spatially resolved atlas of breast cancer uncovers intercellular machinery of venular niche governing lymphocyte extravasation
Nature Communications 2025cited by 13position: middledoi
PCK1 inhibits cGAS-STING activation by consumption of GTP to promote tumor immune evasion
The Journal of Experimental Medicine 2025cited by 8position: middledoi
Spatially resolved atlas of breast cancer uncovers intercellular machinery of venular niche governing lymphocyte extravasation.
2025cited by 6position: contributordoi
PCK1 inhibits cGAS-STING activation by consumption of GTP to promote tumor immune evasion.
2025cited by 6position: contributordoi
Incidence, mortality, and survival associated with acute leukaemia subtypes by age group in China: a population-based cancer registry analysis and cohort study
The Lancet Haematology 2025cited by 5position: middledoi
Effect of cerebellar stimulation on awareness recovery in disorders of consciousness (CARE-DoC): A randomized, sham-controlled, crossover clinical trial
Neurotherapeutics 2025cited by 3position: middledoi
Comparative Analysis of Chilling Injury in Banana Fruit During Storage: Physicochemical and Microstructural Changes, and Early Optical-Based Nondestructive Identification
Foods 2025cited by 3position: middledoi
Identification, Pathogenicity, and Antimicrobial Resistance Analysis of Bacterial Pathogenesis Aeromonas hydrophila from Hybrid Sturgeon (Huso dauricus ♀ × A. schrenckii ♂) in Zhejiang, China
Microorganisms 2025cited by 3position: middledoi
Constructing a pancancer ubiquitination regulatory network to determine tumor characteristics, immunotherapy response, and prognosis.
2025cited by 2position: contributordoi
Identification of an individualized immune-related miRNA pair signature for survival prediction of neoadjuvant chemoradiotherapy in esophageal squamous cell cancer
Cancer Letters 2025cited by 2position: contributordoi
Disease resistance and genetic characteristics of genetically selected largemouth bass (Micropterus salmoides) revealed by whole genome resequencing
Fish & Shellfish Immunology 2025cited by 2position: middledoi
Cell Death and Senescence-Based Molecular Classification and an Individualized Prediction Model for Lung Adenocarcinoma.
2025cited by 1position: contributordoi
A Comprehensive Study on Clinical Outcomes and Safety of Neoadjuvant Immunotherapy Combined With Chemotherapy in Limited-Stage Small Cell Lung Cancer.
2025cited by 1position: contributordoi
CDH3 promotes the progression of lung adenocarcinoma through driving epithelial-mesenchymal transition progress.
2025cited by 1position: contributordoi
Integrated transcriptome and weighted gene co-expression network analyses reveal hepatic metabolic response of largemouth bass (Micropterus salmoides) under hypertonic stress
Aquaculture 2025cited by 1position: middledoi
Tumor-secreted AGR2 induces dendritic cell dysfunction and impairs immunotherapy efficacy in LKB1-deficient cancer.
2025cited by 0position: contributordoi
142P: Identification of the lymph node metastasis atlas and optimal lymph node dissection strategy in patients with resectable lung invasive mucinous adenocarcinoma: A real-world multicentre study
Journal of Thoracic Oncology 2025cited by 0position: firstdoi
Healthy lifestyles of contemporary Chinese population: challenges and new initiatives in primary cancer prevention
The BRICS Health Journal 2025cited by 0position: contributordoi
Cancer incidence and mortality in China, 2022
Journal of the National Cancer Center 2024cited by 1,921position: lastdoi
Perioperative Nivolumab in Resectable Lung Cancer
New England Journal of Medicine 2024cited by 413position: middledoi
Cancer survival statistics in China 2019–2021: a multicenter, population-based study
Journal of the National Cancer Center 2024cited by 92position: contributordoi
Clinical outcomes with perioperative nivolumab (NIVO) by nodal status among patients (pts) with stage III resectable NSCLC: Results from the phase 3 CheckMate 77T study.
Journal of Clinical Oncology 2024cited by 21position: middledoi
Revisiting the CXCL13/CXCR5 axis in the tumor microenvironment in the era of single-cell omics: Implications for immunotherapy
Cancer Letters 2024cited by 18position: contributordoi
A unique circulating microRNA pairs signature serves as a superior tool for early diagnosis of pan-cancer
Cancer Letters 2024cited by 14position: contributordoi
Patterns and prognostic values of programmed cell death-ligand 1 expression and CD8 + T-cell infiltration in small cell carcinoma of the esophagus: a retrospective analysis of 34 years of National Cancer Center data in China.
2024cited by 11position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 88 papers (2019–2026)Jun Qiang · Harbin Medical University20 papers (2014–2025)Pao Xu · Virginia Tech19 papers (2013–2022)Rongshou Zheng · Hangzhou Cancer Hospital14 papers (2016–2024)Hongmei Zeng · Harvard University13 papers (2016–2024)Nan Sun · Huazhong University of Science and Technology13 papers (2018–2025)Siwei Zhang · Jiangnan University12 papers (2016–2023)Wenqiang Wei · Sun Yat-sen University11 papers (2018–2024)Yibo Gao · Chinese Academy of Medical Sciences & Peking Union Medical College11 papers (2019–2023)Dongyu Li · Chinese Academy of Medical Sciences & Peking Union Medical College9 papers (2023–2024)Wanqing Chen · Chinese Academy of Medical Sciences & Peking Union Medical College9 papers (2016–2023) · 8 papers (2024–2025)Dexin Shang · Chinese Academy of Medical Sciences & Peking Union Medical College8 papers (2024–2025)Yifan Tao · Nanjing Agricultural University8 papers (2017–2025)Ru Chen · Taiyuan University of Technology7 papers (2019–2024)Peng Wu · 7 papers (2024–2024)Chaoqi Zhang · Cancer Hospital of Chinese Academy of Medical Sciences7 papers (2024–2024)Ruijie Ma · 7 papers (2024–2024)Junhan Zhou · Chinese Academy of Medical Sciences & Peking Union Medical College7 papers (2024–2024)Jingjing Liu · 7 papers (2024–2024)